Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Istradefylline Effect Protocol on Parkinson's Disease Tremor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of istradefylline on tremor in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • istradefylline (istradefylline)

Snippet

Sponsor: Georgetown University | Conditions: Parkinson Disease, Tremor | Phase 4 | Status: COMPLETED